Chief Scientific Officer
Robyn GoforthRobyn Goforth co-founded University of Arkansas startup BiologicsMD with a lofty goal.
"The road to drug development is so long that many potential medications never reach the end, the patient’s bedside," Goforth said. "As a co-founder of BiologicsMD, my long-term goal is to make that happen. We want to bring the results of academic research on biologics-based medications to the marketplace."
BiologicsMD has developed a patent-pending treatment for osteoporosis that binds to the bone and spurs new bone growth. Goforth and her colleagues took their business plan to unparalleled heights for an Arkansas startup, winning several prestigious international business plan competitions in 2010.
Goforth said the firm's ultimate goal was to license its treatment to a pharmaceutical company once Phase 1 trials were complete.
In addition to her work with BiologicsMD, Goforth is research assistant professor in the Department of Biological Sciences at the UA. She believes the further development of a strong tech-based startup community is important to the future of the state.
"As a long-term resident of Arkansas, I believe that technology-based job creation is vital to our state’s economic future," Goforth said. "Part of what motivates me is the creation of the types of high-paying, knowledge-based jobs that Arkansas needs."
- At Conference, Tyson Foods Touts Stable Earnings, Sales Growth
- Caterpillar to Lay Off 60 in North Little Rock
- Video: Doug McMillon on Why Wal-Mart Chose Jet.com
- Third Walnut Ridge Defendant Gets Shorter Sentence, Co-Conspirators May Benefit 20 hours ago
- Bank of the Ozarks Contributes to Statewide Deposit Growth 1 day ago
- Update: Brenda Montgomery Gets 57 Months in Prison for Lawrence County Bank Theft 2 days ago
- Stocks Say 'Nevermind'; Reverse Recent Losses as Banks Jump 20 hours ago
- Group Asks State Supreme Court to Dismiss Challenge to Liability Proposal 20 hours ago